Nurix Therapeutics Inc (NRIX)

EBITDA Margin

84.03%

Quarterly · Period ending:

NRIX logo

NRIX EBITDA Margin

Latest reported84.03%
NRIX Quarterly EBITDA Margin (-24.08% → 84.03%)
High-resolution chart · PNG

NRIX ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Nurix Therapeutics Inc EBITDA Margin — Quarterly
Period endingEBITDA Margin
84.0265%
-950.5253%
-1,333.9411%
-542.0196%
-1,031.4289%
-85.3618%
-283.0055%
-408.2957%
-355.3225%
-333.8157%
-226.3491%
-251.9889%
-181.9353%
-68.2749%
-296.0426%
-643.9628%
-396.84%
-374.1165%
-418.6675%
-454.4213%
-275.1951%
-363.4043%
-476.5316%
-289.4902%
-456.3525%
-304.5194%
-421.1592%
-698.9796%
-19.4329%
-27.4076%
-24.0849%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.